Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 3
1956 6
1957 4
1961 1
1962 2
1970 1
1972 2
1973 1
1984 1
1985 1
1988 1
1989 4
1990 3
1991 1
1992 2
1994 5
1996 2
1997 4
1998 4
1999 6
2000 2
2001 8
2002 3
2003 6
2004 9
2005 12
2006 12
2007 14
2008 11
2009 14
2010 8
2011 12
2012 10
2013 16
2014 12
2015 17
2016 16
2017 17
2018 12
2019 9
2020 19
2021 31
2022 16
2023 20
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

331 results

Results by year

Filters applied: . Clear all
Page 1
The mouse cortico-basal ganglia-thalamic network.
Foster NN, Barry J, Korobkova L, Garcia L, Gao L, Becerra M, Sherafat Y, Peng B, Li X, Choi JH, Gou L, Zingg B, Azam S, Lo D, Khanjani N, Zhang B, Stanis J, Bowman I, Cotter K, Cao C, Yamashita S, Tugangui A, Li A, Jiang T, Jia X, Feng Z, Aquino S, Mun HS, Zhu M, Santarelli A, Benavidez NL, Song M, Dan G, Fayzullina M, Ustrell S, Boesen T, Johnson DL, Xu H, Bienkowski MS, Yang XW, Gong H, Levine MS, Wickersham I, Luo Q, Hahn JD, Lim BK, Zhang LI, Cepeda C, Hintiryan H, Dong HW. Foster NN, et al. Among authors: aquino s. Nature. 2021 Oct;598(7879):188-194. doi: 10.1038/s41586-021-03993-3. Epub 2021 Oct 6. Nature. 2021. PMID: 34616074 Free PMC article.
Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial.
Gay F, Musto P, Rota-Scalabrini D, Bertamini L, Belotti A, Galli M, Offidani M, Zamagni E, Ledda A, Grasso M, Ballanti S, Spadano A, Cea M, Patriarca F, D'Agostino M, Capra A, Giuliani N, de Fabritiis P, Aquino S, Palmas A, Gamberi B, Zambello R, Petrucci MT, Corradini P, Cavo M, Boccadoro M. Gay F, et al. Among authors: aquino s. Lancet Oncol. 2021 Dec;22(12):1705-1720. doi: 10.1016/S1470-2045(21)00535-0. Epub 2021 Nov 11. Lancet Oncol. 2021. PMID: 34774221 Free article. Clinical Trial.
Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
Cavo M, Gay F, Beksac M, Pantani L, Petrucci MT, Dimopoulos MA, Dozza L, van der Holt B, Zweegman S, Oliva S, van der Velden VHJ, Zamagni E, Palumbo GA, Patriarca F, Montefusco V, Galli M, Maisnar V, Gamberi B, Hansson M, Belotti A, Pour L, Ypma P, Grasso M, Croockewit A, Ballanti S, Offidani M, Vincelli ID, Zambello R, Liberati AM, Andersen NF, Broijl A, Troia R, Pascarella A, Benevolo G, Levin MD, Bos G, Ludwig H, Aquino S, Morelli AM, Wu KL, Boersma R, Hajek R, Durian M, von dem Borne PA, Caravita di Toritto T, Zander T, Driessen C, Specchia G, Waage A, Gimsing P, Mellqvist UH, van Marwijk Kooy M, Minnema M, Mandigers C, Cafro AM, Palmas A, Carvalho S, Spencer A, Boccadoro M, Sonneveld P. Cavo M, et al. Among authors: aquino s. Lancet Haematol. 2020 Jun;7(6):e456-e468. doi: 10.1016/S2352-3026(20)30099-5. Epub 2020 Apr 30. Lancet Haematol. 2020. PMID: 32359506 Clinical Trial.
Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial.
Mina R, Musto P, Rota-Scalabrini D, Paris L, Gamberi B, Palmas A, Aquino S, de Fabritiis P, Giuliani N, De Rosa L, Gozzetti A, Cellini C, Bertamini L, Capra A, Oddolo D, Vincelli ID, Ronconi S, Pavone V, Pescosta N, Cea M, Fioritoni F, Ballanti S, Grasso M, Zamagni E, Belotti A, Boccadoro M, Gay F. Mina R, et al. Among authors: aquino s. Lancet Oncol. 2023 Jan;24(1):64-76. doi: 10.1016/S1470-2045(22)00693-3. Epub 2022 Dec 14. Lancet Oncol. 2023. PMID: 36528035 Clinical Trial.
Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders.
Mikulska M, Testi D, Russo C, Balletto E, Sepulcri C, Bussini L, Dentone C, Magne F, Policarpo S, Campoli C, Miselli F, Cilli A, Ghiggi C, Aquino S, Di Grazia C, Giannella M, Giacobbe DR, Vena A, Raiola AM, Bonifazi F, Zinzani P, Cavo M, Lemoli R, Angelucci E, Viale P, Bassetti M, Bartoletti M. Mikulska M, et al. Among authors: aquino s. Br J Haematol. 2023 May;201(4):628-639. doi: 10.1111/bjh.18690. Epub 2023 Feb 20. Br J Haematol. 2023. PMID: 36806152
Evaluating pulmonary nodules.
Miller JC, Shepard JA, Lanuti M, Aquino S, Thrall JH, Lee SI. Miller JC, et al. Among authors: aquino s. J Am Coll Radiol. 2007 Jun;4(6):422-6. doi: 10.1016/j.jacr.2006.10.006. J Am Coll Radiol. 2007. PMID: 17544146 Review. No abstract available.
Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma.
Sonneveld P, Dimopoulos MA, Beksac M, van der Holt B, Aquino S, Ludwig H, Zweegman S, Zander T, Zamagni E, Wester R, Hajek R, Pantani L, Dozza L, Gay F, Cafro A, De Rosa L, Morelli A, Gregersen H, Gulbrandsen N, Cornelisse P, Troia R, Oliva S, van de Velden V, Wu K, Ypma PF, Bos G, Levin MD, Pour L, Driessen C, Broijl A, Croockewit A, Minnema MC, Waage A, Hveding C, van de Donk NWCJ, Offidani M, Palumbo GA, Spencer A, Boccadoro M, Cavo M. Sonneveld P, et al. Among authors: aquino s. J Clin Oncol. 2021 Nov 10;39(32):3613-3622. doi: 10.1200/JCO.21.01045. Epub 2021 Sep 14. J Clin Oncol. 2021. PMID: 34520219 Clinical Trial.
The globalizability of temporal discounting.
Ruggeri K, Panin A, Vdovic M, Većkalov B, Abdul-Salaam N, Achterberg J, Akil C, Amatya J, Amatya K, Andersen TL, Aquino SD, Arunasalam A, Ashcroft-Jones S, Askelund AD, Ayacaxli N, Sheshdeh AB, Bailey A, Barea Arroyo P, Mejía GB, Benvenuti M, Berge ML, Bermaganbet A, Bibilouri K, Bjørndal LD, Black S, Lyshol JKB, Brik T, Buabang EK, Burghart M, Bursalıoğlu A, Buzayu NM, Čadek M, de Carvalho NM, Cazan AM, Çetinçelik M, Chai VE, Chen P, Chen S, Clay G, D'Ambrogio S, Damnjanović K, Duffy G, Dugue T, Dwarkanath T, Envuladu EA, Erceg N, Esteban-Serna C, Farahat E, Farrokhnia RA, Fawad M, Fedryansyah M, Feng D, Filippi S, Fonollá MA, Freichel R, Freira L, Friedemann M, Gao Z, Ge S, Geiger SJ, George L, Grabovski I, Gracheva A, Gracheva A, Hajian A, Hasan N, Hecht M, Hong X, Hubená B, Ikonomeas AGF, Ilić S, Izydorczyk D, Jakob L, Janssens M, Jarke H, Kácha O, Kalinova KN, Kapingura FM, Karakasheva R, Kasdan DO, Kemel E, Khorrami P, Krawiec JM, Lagidze N, Lazarević A, Lazić A, Lee HS, Lep Ž, Lins S, Lofthus IS, Macchia L, Mamede S, Mamo MA, Maratkyzy L, Mareva S, Marwaha S, McGill L, McParland S, Melnic A, Meyer SA, Mizak S, Mohammed A, Mukhyshbayeva A, Navajas J, Neshevska D, Niaz… See abstract for full author list ➔ Ruggeri K, et al. Among authors: aquino sd. Nat Hum Behav. 2022 Oct;6(10):1386-1397. doi: 10.1038/s41562-022-01392-w. Epub 2022 Jul 11. Nat Hum Behav. 2022. PMID: 35817934 Free PMC article.
Virtual bronchoscopy.
Aquino SL, Vining DJ. Aquino SL, et al. Clin Chest Med. 1999 Dec;20(4):725-30, vii-viii. doi: 10.1016/s0272-5231(05)70251-3. Clin Chest Med. 1999. PMID: 10587794 Review.
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents.
Becherini P, Soncini D, Ravera S, Gelli E, Martinuzzi C, Giorgetti G, Cagnetta A, Guolo F, Ivaldi F, Miglino M, Aquino S, Todoerti K, Neri A, Benzi A, Passalacqua M, Nencioni A, Perrotta I, Gallo Cantafio ME, Amodio N, De Flora A, Bruzzone S, Lemoli RM, Cea M. Becherini P, et al. Among authors: aquino s. Antioxidants (Basel). 2023 Feb 15;12(2):494. doi: 10.3390/antiox12020494. Antioxidants (Basel). 2023. PMID: 36830052 Free PMC article.
331 results